Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- Aileron Therapeutics Inc (NASDAQ:ALRN) has announced initial findings from its ongoing study of ALRN-6924 in healthy volunteers.
- Data were presented at the International Society for Experimental Hematology (ISEH) 50th Annual Scientific Meeting.
- The initial findings demonstrated that a 0.3 mg/kg dose of ALRN-6924 was well tolerated.
- It resulted in p53-mediated induction of the cell cycle inhibitor p21 in healthy, normal bone marrow cells without concurrent induction of apoptosis.
- Related Content: Aileron Launches Early-Stage Study For Chemoprotective Candidate In Lung Cancer Settings.
- Aileron will present final data from the Phase 1b small-cell lung cancer trial and additional data from the healthy volunteer study at the European Society for Medical Oncology (ESMO) Congress.
- Price Action: ALRN shares are down 3.52% at $1.09 during the market session on the last check Friday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!